China’s New IL-1β Blocker for Gout: What Americans Need to Know About Fuxinqibai (Efpelibikibart)

Here’s something that flew under the radar in the American gout community: In May 2026, China approved its first-ever IL-1β inhibitor specifically for acute gout flares. It’s called Fuxinqibai (development code: Efpelibikibart), marketed as Jinbeixin, and the clinical data is genuinely impressive. As someone who’s spent years tracking gout treatments for American patients, I find … Read more

Vitamin C and Gout: What Science Says About Supplements

Vitamin C is often promoted as a natural remedy for gout. But what does the research actually show? This article separates fact from fiction regarding vitamin C supplementation and gout management. Understanding Vitamin C and Uric Acid Vitamin C (ascorbic acid) plays several roles in the body that could theoretically affect uric acid levels: Potential … Read more

Gout and Kidney Disease: Understanding the Two-Way Relationship

Gout and chronic kidney disease (CKD) share a complex, bidirectional (two-way) relationship that significantly impacts patient management. Understanding this connection is crucial for anyone living with either condition. Medically Reviewed by Robert Stevens, MD Research shows that approximately 24% of people with gout eventually progress to stage 3 CKD (moderate damage) or higher. In addition, … Read more

9 Gout Myths Debunked: What Science Actually Says

Gout is one of the most misunderstood diseases. Despite affecting millions of people worldwide, countless myths and misconceptions persist. Believing in these myths can lead to poor management decisions and unnecessary suffering. Let’s separate fact from fiction with evidence-based information from authoritative medical sources. Myth #1: Gout Only Affects the Big Toe The Reality: While … Read more